| Literature DB >> 9437705 |
P J Hunt1, E A Espiner, M G Nicholls, A M Richards, T G Yandle.
Abstract
Human proBNP (purified from cardiac tissue) was incubated at 37 degrees C in whole blood, serum and plasma and the products analyzed by size exclusion high pressure liquid chromatography and radioimmunoassay (RIA). In addition to RIAs for BNP-32 and NT-proBNP(1-13), a newly developed RIA for proBNP(62-76) was also used to identify the peptides. Incubation with serum resulted in the formation of a 9 kDa and a 3 kDa peptide, consistent with the N-terminal and the C-terminal peptides of the propeptide. Minimal processing of proBNP was seen in blood or plasma, suggesting that the circulation does not play a major role in the activation of proBNP. Analysis of degradation products of human proBNP using site directed specific antisera indicates that removal of N-terminal amino acids from proBNP occurs in serum. These findings support the view that the "high molecular weight BNP-32" previously identified in human plasma comprises amino-terminal deleted forms, and is unlikely to be intact proBNP(1-108).Entities:
Mesh:
Substances:
Year: 1997 PMID: 9437705 DOI: 10.1016/s0196-9781(97)00245-3
Source DB: PubMed Journal: Peptides ISSN: 0196-9781 Impact factor: 3.750